JNJ Preview: Medical Devices Should Be the Highlight (RealMoney.com $)
The Street is looking for $1.13 of EPS on $15.2 billion of sales when the company reports Tuesday.
03:26PM 10/12/09
New Play Is Worth the Wait (Deep in the Money Calls $)
It's time to get on board with this health care giant, whose shares have been acting well of late.
09:56AM 07/06/09
JNJ Says Review Of Cougar Biotech Deal Is Complete
Johnson & Johnson says FTC completed antitrust review of Cougar buyout ahead of schedule
07:13AM 06/18/09
China Watch: Yongye Biotechnology
Larry Gilmore, VP of corporate strategy at Yongye Biotechnology, gives an inside look at his company and the agriculture sector in China.
05:00AM 06/17/09
Cougar Biotech Board Backs J&J's $894M Bid
Cougar Biotechnology recommends approval of Johnson & Johnson's $894 million acquisition offer
10:48AM 06/05/09
OncoGenex Prostate Drug Extends Survival
A phase II trial shows OncoGenex's OGX-011 extended the survival of patients with advanced prostate cancer by almost seven months.
04:29PM 05/30/09
Cramer's 'Mad Money' Follow-Up: McDonald's
Here's how stocks Jim Cramer talked about on Tuesday's 'Mad Money' fared on Wednesday.
04:41PM 05/27/09
Mad Money Spotlight: Cougar Biotechnology
Jim Cramer says it's time for shareholders to dump Cougar Biotechnology as it gets subsumed by Johnson & Johnson in a $1 billion buyout.
12:56PM 05/27/09
Cramer's 'Mad Money' Recap: Pullback Playbook (Final)
Cramer says it's important to understand that pullbacks are part of a resilient market and how to take advantage of them. Click for news from Jim Cramer.
06:30PM 05/26/09
General Motors, McClatchy Are Big Movers
General Motors, McClatchy, Ann Taylor, GameStop among big market movers Friday
04:36PM 05/22/09
Here's what some of our market pros are saying and playing.
03:14PM 05/22/09
J&J Just Made Medivation's Day
J&J forks over big money for Cougar, highlighting deep value in Medivation.
09:57AM 05/22/09
J&J To Buy Cougar To Boost Cancer Drug Offering
Johnson & Johnson to acquire Cougar Biotechnology for $43 per share in cash, or $894 million
07:30PM 05/21/09



Connect with TheStreet